Aglaris Limited
Private Limited Company · London
ActiveUnited KingdomIncorporated 2014Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-12-31
IXBRL · 153 source facts · 24 selected values
Validation findingsXBRL valid
Accounts to 2025-12-31
IXBRL · 153 source facts · 24 selected values
Validation findings
XBRL valid
- Reporting period
- 2025-01-01 to 2025-12-31
- Extraction status
- complete
- Numeric facts
- 84
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2607_09111674_20251231
- Source archive
- Accounts_Monthly_Data-July2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-12-31
IXBRL · 150 source facts · 24 selected values
Validation findingsXBRL valid
Accounts to 2024-12-31
IXBRL · 150 source facts · 24 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-01-01 to 2024-12-31
- Extraction status
- complete
- Numeric facts
- 80
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2509_09111674_20241231
- Source archive
- Accounts_Monthly_Data-September2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-12-31
IXBRL · 151 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2023-12-31
IXBRL · 151 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2023-01-01 to 2023-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 82
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2022-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_3200_09111674_20231231
- Source archive
- Accounts_Monthly_Data-December2024.zip
Accounts to 2022-12-31
IXBRL · 153 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2022-12-31
IXBRL · 153 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2022-01-01 to 2022-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 85
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_6666_09111674_20221231
- Source archive
- Accounts_Monthly_Data-December2023.zip
Accounts to 2021-12-31
IXBRL · 160 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2021-12-31
IXBRL · 160 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2021-01-01 to 2021-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 86
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0107_09111674_20211231
- Source archive
- Accounts_Monthly_Data-June2022.zip
Accounts to 2020-12-31
IXBRL · 155 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2020-12-31
IXBRL · 155 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2020-01-01 to 2020-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 85
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0093_09111674_20201231
- Source archive
- Accounts_Monthly_Data-August2021.zip
Accounts to 2019-12-31
IXBRL · 154 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2019-12-31
IXBRL · 154 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2019-01-01 to 2019-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 84
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0082_09111674_20191231
- Source archive
- Accounts_Monthly_Data-September2020.zip
Accounts to 2015-12-31
IXBRL · 35 source facts · 8 selected values
Not assessedlegacy record
Accounts to 2015-12-31
IXBRL · 35 source facts · 8 selected values
Not assessed
legacy record
- Reporting period
- 2014-07-02 to 2015-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 16
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0029_09111674_20151231
- Source archive
- Accounts_Monthly_Data-April2016.zip
Registered details
09111674- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2014-07-02
- Jurisdiction
- —
- Registered office
- 167-169 GREAT PORTLAND STREET, GREAT PORTLAND STREET, LONDON, W1W 5PF, ENGLAND
Classification
1 SIC codes23112
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
2 SH01-derived rounds2024-09-23
£706,091 raised
£13,925,443 estimated post-money
2021-10-18
£158,942 raised
£835,137 estimated post-money
Research and innovation
6 matched grantsDevelopment of transduction process in cell culture platformLead
Innovate UK · Innovation Loans · 2020-07-13 – 2021-07-13
£724,476
awarded
Thermoresponsive Microcarriers for Mesenchymal Stem Cells CulturesLead
Innovate UK · EU-Funded · 2018-10-01 – 2021-05-31
£250,617
awarded
Thermoresponsive Microcarriers for Mesenchymal Stem Cells CulturesLead
EU · EU-Funded · 2018-09-30 – 2021-05-30
£250,617
whole project
Thermoresponsive Microcarriers for Mesenchymal Stem Cells Cultures
EU · EU-Funded · 2018-09-30 – 2021-05-30
£250,617
whole project
Improving T-Cell manufacture through automation - scaling out, reducing costs and increasing quality to meet the emerging demand for patient-tailored cancer therapies.LeadInnovate UK · Collaborative R&D · 2018-07-01 – 2019-09-30 · with 1 other participant£338,053awarded
Improving T-Cell manufacture through automation - scaling out, reducing costs and increasing quality to meet the emerging demand for patient-tailored cancer therapies.Lead
Innovate UK · Collaborative R&D · 2018-07-01 – 2019-09-30 · with 1 other participant
£338,053
awarded
Aglaris Limitedlead£338,053
Future Targeted Healthcare Manufacturing HubEPSRC · Research Grant · 2017-01-01 – 2024-12-31 · with 90 other participants£10,851,089whole project
Future Targeted Healthcare Manufacturing Hub
EPSRC · Research Grant · 2017-01-01 – 2024-12-31 · with 90 other participants
£10,851,089
whole project
University College Londonlead3MAdaptimmuneAglaris LtdAlbumedix LtdAlbumedix LtdAllerganAllergan Limited (UK)Applikon Biotechnology B.V.Association of the British Pharmaceutical IndustryAssoc of the British Pharm Ind (ABPI)AstrazenecaAstraZenecaAutolusAutolus LimitedAutolus LtdBIA SeparationsBioindustry AssociationBioLogicB LLCBioLogicB, LLCBiopharm ServicesBiopharm Services LimitedCancer Research UKCell And Gene Therapy CatapultCell Medica Ltd.Celltech Group plcCell Therapy CatapultCentre for Process InnovationCentre for Process Innovation (CPI)CSL BehringdeltaDOT LtdEli Lilly & Company LtdEli Lilly S.A. - Irish BranchFloDesign SonicsFrancis BiopharmaFrancis Biopharma LtdFujifilmFujifilm UK LtdGlaxoSmithKline (GSK)GskImperial College LondonIpsenIrvine ScientificKnowledge Transfer NetworkKnowledge Transfer Network LimitedKuopio Center for Gene and Cell TherapyLaboratory of the Government Chemist (LGC) LtdLgcLgc LtdLonza Biologics PLCLonza GroupMedicines & Healthcare pdts Reg Acy MHRAMedicines Manufacturing Ind PartnershipMedicines Manufacturing Industry PartnershipMerck KGaAMerck Sharpe and DohmeNational Institute for Biological Standards and Control (NIBSC)Novo Nordisk A/SOrchard TherapeuticsOvizio Imaging Systems NV SAOxford BioMedica UK LtdOxford BioMedica (United Kingdom)Pall EuropePerceptive Engineering LimitedPerceptive Engineering LtdPfizerPharmaronPuridifyPuridify LTDPurolite International LtdRedbud LabsReneuronReneuron LtdRepligenRoche Diagnostics GmbHSartoriusSartorius Stedim UK LimitedShanghai Pulmonary HospitalSsc BioSutro BiopharmaTillingbourne Consulting LimitedTrakCelUcb SAUK BioIndustry Association (BIA)United Kingdom Research and InnovationUnivercells LtdUniversity College LondonUniversity of WarwickWest Pharmaceutical ServicesWyatt Technology CorporationWyatt Technology UK Ltd